213 related articles for article (PubMed ID: 27862681)
1. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease.
Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur J Pain; 2017 Apr; 21(4):658-667. PubMed ID: 27862681
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study.
Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Karttunen N; Pylkkänen L; Tiihonen J; Hartikainen S
Pain; 2017 Feb; 158(2):252-260. PubMed ID: 28092324
[TBL] [Abstract][Full Text] [Related]
3. Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease.
Lintula E; Tiihonen M; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Hamina A
Drugs Aging; 2020 Mar; 37(3):193-203. PubMed ID: 31879863
[TBL] [Abstract][Full Text] [Related]
4. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.
Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
Int J Geriatr Psychiatry; 2019 Feb; 34(2):280-288. PubMed ID: 30370943
[TBL] [Abstract][Full Text] [Related]
5. Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland.
Bell SJ; Laitinen ML; Lavikainen P; Lönnroos E; Uosukainen H; Hartikainen S
Pain; 2011 Mar; 152(3):543-547. PubMed ID: 21247697
[TBL] [Abstract][Full Text] [Related]
6. Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease.
Hamina A; Taipale H; Karttunen N; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
J Alzheimers Dis; 2019; 69(3):807-816. PubMed ID: 31127778
[TBL] [Abstract][Full Text] [Related]
7. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
[TBL] [Abstract][Full Text] [Related]
8. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.
Tiihonen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 52(1):127-32. PubMed ID: 26967224
[TBL] [Abstract][Full Text] [Related]
11. Depressive symptoms are associated with analgesic use in people with Alzheimer's disease: Kuopio ALSOVA study.
Gilmartin JF; Väätäinen S; Törmälehto S; Bell JS; Lönnroos E; Salo L; Hallikainen I; Martikainen J; Koivisto AM;
PLoS One; 2015; 10(2):e0117926. PubMed ID: 25688858
[TBL] [Abstract][Full Text] [Related]
12. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
Järvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
J Alzheimers Dis; 2018; 64(2):437-445. PubMed ID: 29914029
[TBL] [Abstract][Full Text] [Related]
13. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
Rajamaki B; Hartikainen S; Tolppanen AM
BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease.
Taipale H; Vuorikari H; Tanskanen A; Koponen M; Tiihonen J; Kettunen R; Hartikainen S
Drugs Aging; 2015 Nov; 32(11):937-45. PubMed ID: 26476844
[TBL] [Abstract][Full Text] [Related]
15. Balancing pain and analgesic treatment in the home-dwelling elderly.
Hartikainen SA; Mäntyselkä PT; Louhivuori-Laako KA; Sulkava RO
Ann Pharmacother; 2005 Jan; 39(1):11-6. PubMed ID: 15598966
[TBL] [Abstract][Full Text] [Related]
16. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
Sarycheva T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2018; 66(1):387-395. PubMed ID: 30282366
[TBL] [Abstract][Full Text] [Related]
18. Analgesic use among community-dwelling people aged 75 years and older: A population-based interview study.
Pokela N; Bell JS; Lihavainen K; Sulkava R; Hartikainen S
Am J Geriatr Pharmacother; 2010 Jun; 8(3):233-44. PubMed ID: 20624613
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.
Torvinen-Kiiskinen S; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2017 Dec; 32(12):e107-e115. PubMed ID: 28055139
[TBL] [Abstract][Full Text] [Related]
20. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]